Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Murphy USA Inc. Director's Dealing 2022

Feb 25, 2022

30773_dirs_2022-02-25_39a40634-1218-480a-adc1-ed2fdc9530c2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Murphy USA Inc. (MUSA)
CIK: 0001573516
Period of Report: 2022-02-10

Reporting Person: Bridges Jennifer (SVP, Asset Development)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $71.00 2025-02-07 Common Stock (2400) Direct
Stock Option $76.15 2026-02-06 Common Stock (2400) Direct
Stock Option $106.72 2027-02-05 Common Stock (1800) Direct
Stock Option $126.00 2028-02-10 Common Stock (2100) Direct
Stock Option $181.18 2029-02-09 Common Stock (1400) Direct
Restricted Stock Unit $ Common Stock (500) Direct
Restricted Stock Unit $ Common Stock (500) Direct
Restricted Stock Unit $ Common Stock (400) Direct
Performance Stock Unit $ Common Stock (1000) Direct
Performance Stock Unit $ Common Stock (1000) Direct
Performance Stock Unit $ Common Stock (800) Direct
Dividend Equivalent Units $ Common Stock (23.742) Direct

Footnotes

F1: The option vests in two equal installments. The first installment of 1200 shares became exercisable on February 7, 2020 and the second installment of 1,200 shares became exercisable on February 7, 2021.

F2: The option vests in two equal installments. The first installment of 1200 shares became exercisable on February 6, 2021 and the second installment of 1,200 shares became exercisable on February 6, 2022.

F3: The option vests in two equal installments. The first installment of 900 shares became exercisable on February 5, 2022 and the second installment of 900 shares will become exercisable on February 5, 2023.

F4: The option vests in two equal installments. The first installment of 1,050 shares will become exercisable on February 10, 2023 and the second installment of 1,050 shares will become exercisable on February 10, 2024.

F5: The option vests in two equal installments. The first installment of 700 shares will become exercisable on February 9, 2024 and the second installment of 700 shares will become exercisable on February 9, 2025.

F6: The Restricted Stock Unit vest on February 5, 2023.

F7: The Restricted Stock Unit vest on February 10, 2024.

F8: The Restricted Stock Unit vest on February 9, 2025.

F9: These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date.

F10: Reflects dividend equivalent units accrued on RSUs granted to the Reporting Person under the Plan. Each dividend equivalent unit reflects the right to receive common stock, subject to the terms and conditions (including vesting and settlement terms) applicable to the corresponding RSUs.